Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital, Lille
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with relapsing-remitting multiple sclerosis receiving high-efficacy or non-high-efficacy treatment and follow-up at the CRCSEP of the Lille University Hospital through past participation in the VWIMS study.
Male and/or female participants in the VWIMS research project
At least 18 years of age at the time of inclusion in VWIMS - II
Patient having given written consent to participate in the study
Socially insured patient
Patient willing to comply with all study procedures and duration
You may not be if
Age \< 18 years
Other neurological pathologies that may interfere with MRI and/or OCT data (diabetes, retinopathy \[any cause\], glaucoma, retinal detachment, ametropia \> 6 diopters)
Contraindications to MRI (claustrophobia, incompatible metal foreign bodies such as certain pacemakers and mechanical valves, cochlear implants, intra-orbital metal splinters, pregnancy, certain brands of IUD because of the 3 Tesla magnetic field).
Contraindication to injection: severe renal failure with creatine clearance \<30, allergy to contrast media, pregnancy, breast-feeding.
Pregnant women
Nursing women
Persons incapable of giving consent on their own, with or without legal protection (guardianship/curatorship)
Person under legal protection
Persons deprived of their liberty
Administrative reasons: inability to receive informed information, inability to participate in the entire study, lack of social security coverage, refusal to sign consent form
Clareo Health | Visual (Path)Ways in Multiple Sclerosis - Part II
